1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow EDI048: new trials by email Literature Review of EDI048 trials Research Report on EDI048
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults Cryptosporidium parvum oocysts (ABO809), EDI048, Placebo - Cryptosporidiosis | Phase 2 | Recruiting | Novartis Pharmaceuticals | 80 | 2025-12-08 | 2026-08-19 |
| First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers EDI048, Placebo - Healthy Volunteers | Phase 1 | Completed | Novartis Pharmaceuticals | 110 | 2022-04-29 | 2025-01-10 |
United Kingdom (1) · United States (1)